These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3802715)

  • 21. [Electron microscopic observations of liver and kidney of mous e treated with lead and ethanol, and variation of delta-ALA in urine and delta-ALA-D activities in blood (author's transl)].
    Miyazaki T; Kaneko Y; Nishimura M
    Sangyo Igaku; 1977 Jul; 19(4):196-7. PubMed ID: 592544
    [No Abstract]   [Full Text] [Related]  

  • 22. Neurochemical aspects of porphyria. Studies on the possible neurotoxicity of delta-aminolaevulinic acid.
    Shanley BC; Neethling AC; Percy VA; Carstens M
    S Afr Med J; 1975 Mar; 49(14):576-80. PubMed ID: 1145380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of the porphyrin precursors delta-aminolaevulinic acid (ALA) and porphobilinogen (PBG) in the acute attack of porphyria.
    Kramer S; Becker D; Viljoen D
    S Afr Med J; 1973 Sep; 47(38):1735-8. PubMed ID: 4270402
    [No Abstract]   [Full Text] [Related]  

  • 24. Porphyrin precursors in acute porphyria.
    Eales L
    S Afr Med J; 1978 Jan; 53(3):79-80. PubMed ID: 653477
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities.
    McColl KE; Moore MR; Thompson GG; Goldberg A
    J Med Genet; 1982 Aug; 19(4):271-6. PubMed ID: 7120315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation of protoporphyrin IX from delta-aminolevulinic acid in bovine skin fibroblasts with hereditary erythropoietic protoporphyria. A gene-dosage effect.
    Sassa S; Schwartz S; Ruth G
    J Exp Med; 1981 May; 153(5):1094-101. PubMed ID: 6788885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic fate of exogenous delta-aminolevulinic acid in Dubin-Johnson syndrome.
    Kondo T; Kuchiba K; Shimizu Y
    J Lab Clin Med; 1979 Sep; 94(3):421-8. PubMed ID: 469378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delta-aminolevulinic acid in plasma by free amino acid analysis.
    Hannan CJ; Kettler T; Dabe I; Clark T
    Clin Chem; 1989 Sep; 35(9):1998. PubMed ID: 2776336
    [No Abstract]   [Full Text] [Related]  

  • 29. Porphyrin biosynthesis from ALA and PBG by human erythrocytes in porphyrin disorders. Kinetic studies of the isomer series I and III.
    Schermuly E; Doss M
    Ann Clin Res; 1976; 8 Suppl 17():92-102. PubMed ID: 1008503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue uptake of o-aminolaevulinic acid.
    McGillion FB; Thompson GG; Goldberg A
    Biochem Pharmacol; 1975 Jan; 24(2):99-301. PubMed ID: 1111547
    [No Abstract]   [Full Text] [Related]  

  • 31. Oxidative stress in acute intermittent porphyria and lead poisoning may be triggered by 5-aminolevulinic acid.
    Bechara EJ
    Braz J Med Biol Res; 1996 Jul; 29(7):841-51. PubMed ID: 9070373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of L-arginine transport in undialysed chronic renal failure and continuous ambulatory peritoneal dialysis patients.
    Brunini TM; Roberts NB; Yaqoob MM; Ellory JC; Mann GE; Mendes Ribeiro AC
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):114-8. PubMed ID: 16445709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of delta-aminolaevulinic acid and porphobilinogen to alter renal salt and water excretion in the dog.
    Unikowsky B; Levy M
    Can J Physiol Pharmacol; 1983 Apr; 61(4):363-8. PubMed ID: 6860998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools.
    Bonkovsky HL; Healey JF; Lourie AN; Gerron GG
    Am J Gastroenterol; 1991 Aug; 86(8):1050-6. PubMed ID: 1713408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnancy and the acute porphyrias.
    Brodie MJ; Moore MR; Thompson GG; Goldberg A; Low RA
    Br J Obstet Gynaecol; 1977 Oct; 84(10):726-31. PubMed ID: 921907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait.
    Sassa S; Solish G; Levere RD; Kappas A
    J Exp Med; 1975 Sep; 142(3):722-31. PubMed ID: 1165472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the biosynthesis of porphyrins in erythrocytes after incubation with delta-aminolevulinic acid: an attempt to investigate the pathogenesis of nephrogenic anemia.
    Ivanov E; Pisanets M
    Acta Biol Med Ger; 1982; 41(4):307-13. PubMed ID: 7124248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of active oxygen species during coupled autoxidation of oxyhemoglobin and delta-aminolevulinic acid.
    Monteiro HP; Abdalla DS; Faljoni-Alàrio A; Bechara EJ
    Biochim Biophys Acta; 1986 Mar; 881(1):100-6. PubMed ID: 3081047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies in porphyria. V. Drug oxidation rates in hereditary hepatic porphyria.
    Anderson KE; Alvares AP; Sassa S; Kappas A
    Clin Pharmacol Ther; 1976 Jan; 19(1):47-54. PubMed ID: 1245093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.